Theophylline synergizes with chlorambucil in inducing apoptosis of B- chronic lymphocytic leukemia cells

Blood

Volumn 88, Issue 6, 1996, Pages 2172-2182

  Mentz, Frank ^a   Mossalayi, M Djavad ^a   Ouaaz, Fateh ^a   Baudet, Sylvie ^a   Issaly, Françoise ^a   Ktorza, Sandra ^a   Semichon, Monique ^a   Binet, Jacques Louis ^a   Merle Beral, Hélène ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHLORAMBUCIL; INTERLEUKIN 4; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P53; THEOPHYLLINE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029815706     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2172.bloodjournal8862172     Document Type: Article

References (65)

1. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T-cells in thymic culture. Nature 337:181, 1989
2. Nieman PE, Thomas SJ, Loring G: Induction of apoptosis during normal and neoplastic B-cell development in the bursa of fabricius. Proc Natl Acad Sci USA 88:5857, 1991
3. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097, 1991
4. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
5. Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JFR: Spontaneous programmed death (apoptosis) of B chronic lymphocytic leukemia cells following their culture in vitro. Br J Haematol 71:343, 1989
6. McConkey DJ, Aguilar-Santelises M, Hartzell P, Eriksson I, Mellstedt H, Orrenius S, Jondal M: Induction of DNA fragmentation in chronic B lymphocytic leukemia cells. J Immunol 146:1072, 1991
7. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W: Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinofuranosyl-2-fluoroadenine. Blood 81:143, 1993
8. Begleiter A, Lee K, Israels LG, Mowat MR, Johnston JB: Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficiency. Leuk Lymphoma 8:103, 1994 suppl 1
9. Forbes IJ, Zalewski PD, Giannakis C, Cowled PA: Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 198:367, 1992
10. Mentz F, Merle-Béral H, Ouaaz F, Binet JL: Theophylline, a new inducer of apoptosis in B-CLL. Role of cyclic nucleotides. Br J Haematol 90:957, 1995
11. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B chronic lymphocytic leukemia cells. J Exp Med 179:91, 1994
12. Mainou-Fowler T, Craig VA, Copplestone JA, Hamon MD, Prentice AG: Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. Blood 84:2297, 1994
13. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and up regulates Bcl-2 expression. J Exp Med 176:1319, 1992
14. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand A, Bienner MK: Interferon γ inhibits apoptotic cell death in B-cell chronic lymphocytic leukemia. J Exp Med 177:213, 1993
15. Chaouchi N, Wallon C, Taieb J, Auffredou MT, Tertian G, Lemoine FM, Delfraissy JF, Vasquez A: Interferon α-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc. Clin Immunol Immunopathol 73:197, 1994
16. Sachs L, Lotem J: Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15, 1993
17. Hockenberry D, Nunez G, Millman C, Shreiber RD, Korsmeyer SJ: Bcl-2, an inner mitochondrial protein that blocks programmed cell death. Nature 348:334, 1990
18. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
19. Schena M, Larsson LG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F: Growth and differentiation-associated of BCL-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981, 1992
20. Raghoebier S, Van Krieken JH, Kluin-Nelemans JC, Gillis A, Van Ommer GJB, Ginsberg AM, Raffeld M, Kluin PM: Oncogene rearrangements in chronic B-cell leukemia. Blood 77:1560, 1991
21. Prokocimer M, Rotter V: Structure and function of p53 in normal cells and their aberration in cancer cells: Projection on the hematologic cell lineages. Blood 84:2391, 1994
22. Fenaux P, Prudhomme C, Lai JL, Quinquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MH, Bauters F, Burger P, Kerckaert JP: Mutations of p53 gene in B-cell chronic lymphocytic leukemia: A report of 39 cases with cytogenetic analysis. Leukemia 6:246, 1992
23. Lotem J, Sachs L: Regulation by Bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells. Cell Growth Differ 4:41, 1993
24. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119, 1992
25. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastatis Rev 11:95, 1992
26. Mentz F, Ouaaz F, Michel A, Blanc C, Hervé P, Bismuth G, Debré P, Merle-Béral H, Mossalayi DM: Maturation of acute T lymphoblastic leukemia cells following CD2-ligation and subsequent treatment with interleukin-2. Blood 84:1182, 1994
27. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440, 1985
28. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A laboratory manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1985
29. Kebabian JW: The cyclic AMP cascade: A signal transduction system. Neurotransmissions 2:1, 1992
30. Miyashita T, Reed JC: BCL-2 gene transfer increases relative resistance of S49.1 and WEH 17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407, 1992
31. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
32. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
33. Albert D, Kowalski J, Nodzenski E, Micek M, Wu P: The dose dependent effect of cyclic AMP on ribonucleotide reductase in mitogen stimulated mononuclear cells. Biochem Biophys Res Commun 167:383, 1990
34. Kizaki H, Suzuki K, Tadakuma T, Ishimura Y: Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J Biol Chem 265:5280, 1990
35. McConkey DJ, Orrenius S, Jondal M: Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol 145:1227, 1990
36. Mentz F, Mossalayi MD, Ouaaz F, Debré P: Involvement of cAMP in CD3/T cell receptor complex- and CD2-mediated apoptosis of human thymocytes. Eur J Immunol 25:1798, 1995
37. Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB: TGFβ1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 154:1634, 1995
38. Knox KA, Johnson GD, Gordon J: Distribution of cAMP in secondary follicles and its expression in B cell apoptosis and CD40-mediated survival. Int Immunol 5:1085, 1993
39. Lalli E, Sassone-Corsi P: Signal transduction and gene regulation: The nuclear response to cAMP. J Biol Chem 269:17359, 1994
40. Cohen JJ, Duke RC: Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:38, 1984
41. Knox KA, Gordon J: Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis. Eur J Immunol 23:2578, 1993
42. Lee S, Christakos S, Small MB: Apoptosis and signal transduction: Clues to a molecular mechanism. Curr Opin Cell Biol 5:286, 1993
43. 2+ cyclic AMP interactions in sustained cellular responses. Ciba Found Symp 164:98, 1992
44. Choi EJ, Xia Z, Villacres EC, Storm DR: The regulatory diversity of the mammalian adenylyl cyclases. Curr Opin Cell Biol 5:269, 1993
45. 6-benzylguanine and ethacrynic acid in haematological malignancies. Anticancer Res 13:2155, 1993
46. Frankfurt OS, Byrnes JJ, Seckinger D, Sugarbaker EV: Apoptosis (programmed cell death) and the evaluation of chemosensitivity in chronic lymphocytic leukemia and lymphoma. Oncol Res 5:37, 1993
47. Luo HY, Ruhio M, Biron G, Delespesse G, Sarfati M: Anti-proliferative effect of interleukin-4 in B chronic lymphocytic leukemia. J Immunother 10:418, 1991
48. 1-positive acute lymphoblastic leukemia cells. Blood 78:1574, 1991
49. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand V: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 85:439, 1993
50. Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui CH, Campana D: Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 83:1731, 1994
51. Law CL, Armitage RJ, Villablanca JG, LeBien TW: Expression of interleukin-4 receptors on early human B-lineage cells. Blood 78:703, 1991
52. Keegan AD, Nelms K, Wang LM, Pierce JH, Paul WE: Interleukin-4 receptor: Signaling mechanisms. Immunol Today 15:423, 1994
53. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ:BCL-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
54. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554, 1992
55. Bissonnette RP, Echeverri F, Mahboudi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552, 1992
56. Harrington EA, Bennet MR, Fanidi A, Evan GI: c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286, 1994
57. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523, 1992
58. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J: Induction of apoptosis by wild-type p53 in a humancolon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495, 1992
59. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846, 1992
60. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in cellular response to DNA damage. Cancer Res, 51:6304, 1991
61. Hermeking H, Eick D: Mediation of c-myc-induced apoptosis by p53. Science 265:2091, 1994
62. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
63. Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC, Pierotti MA: Regulation of apoptosis induced by the retinoid N - (4-Hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 85:359, 1995
64. Schwartz LM, Osborne BA: Programmed cell death, apoptosis and killer genes. Immunol Today 14:582, 1993
65. Binet JL, Mentz F, Leblond V, Merle-Béral H: Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia. Leukemia 9:2159, 1995